Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. - Wikidata - wikimedia - TriplyDB

Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.

Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.

http://www.wikidata.org/entity/Q39318833

about

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection Chronic hepatitis C virus infection and lipoprotein metabolism Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance Hunting Viral Receptors Using Haploid Cells The missing pieces of the HCV entry puzzle.Regulated Entry of Hepatitis C Virus into Hepatocytes.Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.Hepatitis C virus life cycle and lipid metabolism Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus.A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.The ins and outs of hepatitis C virus entry and assembly.Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus How hepatitis C virus invades hepatocytes: the mystery of viral entry Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection.Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection.Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein.The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.Disruption of Claudin-1 Expression by miRNA-182 Alters the Susceptibility to Viral Infectivity in HCV Cell Models.Hepatitis C virus: Morphogenesis, infection and therapy.Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.

P2860

Q26779128-316FF220-432D-4591-97C8-F7AE0571F16B Q26784234-8BAB290A-0EB9-4FC5-968E-322FC2D421D6 Q26801759-61A25F5E-6449-4359-AE67-CE8636A279E7 Q26864485-D4F7B3F2-D198-41E9-8C5F-D4596E51604E Q27469038-0114BC2B-81C8-4BA4-8371-6DCCBF59E8E8 Q28080327-2E62781F-A77C-4853-B456-68D50BF01340 Q33360674-0527A2C4-0B79-4F4B-8338-AEF5C718DCD5 Q33753913-035AD625-3600-409D-9320-0CE830D0F3D3 Q34416004-FB87AF8A-DB13-48E4-A521-25757D7F39C1 Q34594986-87B9F4B3-A445-4258-9D30-F069F476910B Q34792436-47A0B120-103B-464C-AECA-07348F5D5EB4 Q35125004-5DF773AC-BCC8-4693-85C0-47D73EF5B8D2 Q35557533-387FBAC9-9DD4-4CD6-B45B-C02B437B4684 Q35727227-31DFFFF5-5B6C-4D4F-BBEE-AB83495778CB Q35832687-A99CCAC2-CBEF-41A1-BC6B-74BCFD9FC789 Q35861270-CAF0C95F-D906-4882-9352-6BD8C0B8B05D Q35914270-70A0AA44-10AA-4D3D-BB95-921018550B4D Q36010861-B26A753C-28E9-472A-9128-8EE48F301547 Q36133495-631EA347-0FEB-40D9-9217-0D4457599039 Q36233117-18E6EA5D-D4B8-4BEA-871A-E2E134C9A513 Q36281615-189272AE-5CED-42A6-B57E-4789B4E7D4BE Q36694134-FA9C2E6E-9F66-434A-8CB4-BE8BD3C7C4D7 Q37015738-AC1A71DD-83D3-4770-B3F9-BABE142ACE95 Q37498626-DBA3208A-F5CF-46F4-87A3-F1800493CF9D Q37547255-8EB591DB-475F-40C7-944E-6FC8A75C3E80 Q37682499-6C9F5713-014F-420A-AA1B-88B0DB74BD82 Q38103293-1FEFD304-0CE2-4012-8045-562E82C31AE8 Q38166372-1B6AB517-EDC3-4EAB-97E6-50D5094FB101 Q38728564-F48605F5-608A-498B-8862-115B6084937B Q38765582-1AB1BC5A-1540-4D37-A502-602E12111907 Q38964215-EF5E5BF2-EB2D-4184-98E7-7877C219E01A Q39232151-90D7D3C3-8BCE-4C6F-9322-C33A76F90BEF Q39256583-E42BAB0D-DA22-46D4-B34C-D0F9C7270983 Q39380623-F9161B90-25F8-4D8F-937C-C801E6E87C97 Q39480497-5B0B7D2B-85F4-4A9E-B655-84A4AF855275 Q42269411-31BF2E98-A35D-4968-ACD7-B0FE5E05C3E7 Q47280477-78617D00-6350-4AD9-A1B3-F5BFFA71F327 Q52332712-F7CE0E1C-BA97-4253-95D4-7B34E54342E2 Q52661702-E2250052-FE13-4681-BAD5-C5C33971E82B Q53683152-438A6278-CF4A-4D42-8994-CC8DF1578374

P2860

Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.

http://www.wikidata.org/entity/Q39318833

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Characterization of hepatitis ...... r receptor BI for entry steps.

@en

Characterization of hepatitis ...... r receptor BI for entry steps.

@nl

type

label

Characterization of hepatitis ...... r receptor BI for entry steps.

@en

Characterization of hepatitis ...... r receptor BI for entry steps.

@nl

prefLabel

Characterization of hepatitis ...... r receptor BI for entry steps.

@en

Characterization of hepatitis ...... r receptor BI for entry steps.

@nl

P1433

Q39318833-27F0DD8F-F11F-4C34-A314-78B7831F7A91

P1476

Q39318833-5AFBEB3F-14A8-4C72-98BB-3283B4C4CB45

P2093

Q39318833-661A3EE6-1A18-48A4-83A8-0DB14AF885C6

Q39318833-68D047F9-9653-4416-BF54-0D48118166C2

Q39318833-7A4AF648-B4FA-4559-8834-4E241A406A0C

Q39318833-AD594DCB-F867-48D3-918A-198143AC5FA5

Q39318833-ADEB6E98-9F06-4A22-AAE9-580C26CB00F0

Q39318833-CFF128CA-4D28-4C66-BE62-3FC9A83718F9

P2860

Q39318833-01CB4CCB-ECA4-4FB0-8F8E-E2A1A71B1BBF

Q39318833-021CECCC-DC52-44D8-81ED-AB6CE006E6DB

Q39318833-0290E6F5-5595-462F-ACCC-9F39823A2E32

Q39318833-05312828-12F3-465E-B0BC-9BCB3D4C51CC

Q39318833-0819B226-241D-42FD-9425-139C43BA84F3

Q39318833-0888D1EF-5D9D-42B0-8EF5-0CBC09BC7EE6

Q39318833-0A43FB9D-5FBB-4CE5-9437-FA47B9257B9A

Q39318833-0BDBE6FF-8EA4-4CA4-88F0-3E49C045A8B4

Q39318833-0C775068-C9C7-4361-B224-EB602D1D8EC0

Q39318833-0D4AAFD8-74C2-4E1F-816F-A461893BDF70

P304

Q39318833-7F86C725-2203-45D7-AEF3-F25A3FD28542

P31

Q39318833-A291B87C-C602-4E92-B988-A25E0D2F02FF

P356

Q39318833-E9506CC2-E142-41A8-821E-26CEB1B38B11

P407

Q39318833-E6651EAF-1D3D-40CB-9DA1-1C8392333C8A

P433

Q39318833-9489423B-8515-4296-9801-8CF802D9C0D6

P478

Q39318833-A51490BD-5E17-4600-984F-4C6F13F9D552

P50

Q39318833-176FB38F-C8CF-4CC4-A774-17E2E1AE9A47

Q39318833-7CD7BE3B-C796-4B66-B917-64B412647EC9

Q39318833-8E844E3F-7ABF-492C-8537-80E9B056DD39

Q39318833-A1A19340-5947-46A1-B96F-C605B681D6F2

Q39318833-B5AFFD3A-D767-4C3E-B190-9CBC65B0F809

Q39318833-DC926C4B-81B2-4E98-9AE7-B681B2D5BF7E

P577

Q39318833-A0475915-37BD-41F5-B416-4D119191F529

P5875

Q39318833-25870816-7A5C-4B82-9D7D-7026DB88CD28

P698

Q39318833-E1A5FD67-2CA3-4243-AF21-30E2D8312D3A

P932

Q39318833-792FF2B4-EEC0-446D-B0DF-4E5C8E7EA551

P356

JBC.M112.365924

P1433

Journal of Biological Chemistry

P1476

Characterization of hepatitis ...... er receptor BI for entry steps

@en

P2093

Christelle Granier

http://www.w3.org/2001/XMLSchema#string

François Penin

http://www.w3.org/2001/XMLSchema#string

Jimmy Mancip

http://www.w3.org/2001/XMLSchema#string

Maryse Guérin

http://www.w3.org/2001/XMLSchema#string

Ophélia Granio

http://www.w3.org/2001/XMLSchema#string

Thomas F Baumert

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

Binding of hepatitis C virus to CD81

Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

Robust hepatitis C virus infection in vitro.

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

P304

31242-31257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M112.365924

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P50

Ralf Bartenschlager

François-Loïc Cosset

Dimitri Lavillette

Viet Loan Dao Thi

P577

2012-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228331382

http://www.w3.org/2001/XMLSchema#string

P698

22767607

http://www.w3.org/2001/XMLSchema#string

P932

3438956

http://www.w3.org/2001/XMLSchema#string